Fumitaka Terabe

1.4k total citations
16 papers, 1.1k citations indexed

About

Fumitaka Terabe is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Fumitaka Terabe has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Fumitaka Terabe's work include Inflammatory Bowel Disease (3 papers), Ocular Diseases and Behçet’s Syndrome (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Fumitaka Terabe is often cited by papers focused on Inflammatory Bowel Disease (3 papers), Ocular Diseases and Behçet’s Syndrome (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Fumitaka Terabe collaborates with scholars based in Japan, United States and India. Fumitaka Terabe's co-authors include Tetsuji Naka, Minoru Fujimoto, Satoshi Serada, Tadamitsu Kishimoto, Tomoharu Ohkawara, Shintaro Nomura, Teppei Nishikawa, Barry Ripley, Akihiro Kimura and Nobuyuki Ohguro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and American Journal Of Pathology.

In The Last Decade

Fumitaka Terabe

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fumitaka Terabe Japan 12 463 365 234 215 198 16 1.1k
Noriyoshi Ogawa Japan 23 532 1.1× 237 0.6× 307 1.3× 372 1.7× 183 0.9× 81 1.6k
Amer M. Mirza United States 16 334 0.7× 316 0.9× 572 2.4× 110 0.5× 77 0.4× 32 1.3k
Toshihiro Fukushima Japan 20 157 0.3× 382 1.0× 299 1.3× 229 1.1× 133 0.7× 77 1.1k
Ebrahim Sakhinia Iran 22 184 0.4× 266 0.7× 681 2.9× 121 0.6× 243 1.2× 73 1.3k
Tsan‐Teng Ou Taiwan 16 409 0.9× 164 0.4× 246 1.1× 344 1.6× 100 0.5× 59 997
Georg Weinlich Austria 16 582 1.3× 389 1.1× 371 1.6× 101 0.5× 94 0.5× 27 1.4k
Dongyi He China 19 511 1.1× 179 0.5× 480 2.1× 602 2.8× 133 0.7× 56 1.5k
Weronika Kurowska Poland 16 328 0.7× 178 0.5× 388 1.7× 370 1.7× 67 0.3× 27 1.0k
Kimito Kawahata Japan 18 584 1.3× 181 0.5× 320 1.4× 259 1.2× 72 0.4× 82 1.3k
Ke Liu China 17 276 0.6× 176 0.5× 414 1.8× 237 1.1× 40 0.2× 48 1.1k

Countries citing papers authored by Fumitaka Terabe

Since Specialization
Citations

This map shows the geographic impact of Fumitaka Terabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumitaka Terabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumitaka Terabe more than expected).

Fields of papers citing papers by Fumitaka Terabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumitaka Terabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumitaka Terabe. The network helps show where Fumitaka Terabe may publish in the future.

Co-authorship network of co-authors of Fumitaka Terabe

This figure shows the co-authorship network connecting the top 25 collaborators of Fumitaka Terabe. A scholar is included among the top collaborators of Fumitaka Terabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumitaka Terabe. Fumitaka Terabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Terabe, Fumitaka, et al.. (2014). [A case of pancreatic pseudocyst associated with pancreatic cancer successfully treated with endoscopic pseudocyst drainage, which allowed continuation of chemotherapy].. PubMed. 41(12). 2211–3. 1 indexed citations
2.
Serada, Satoshi, Minoru Fujimoto, Fumitaka Terabe, et al.. (2012). Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis. Inflammatory Bowel Diseases. 18(11). 2169–2179. 167 indexed citations
3.
Kitaba, Shun, Hiroyuki Murota, Mika Terao, et al.. (2011). Blockade of Interleukin-6 Receptor Alleviates Disease in Mouse Model of Scleroderma. American Journal Of Pathology. 180(1). 165–176. 97 indexed citations
4.
Ohguro, Nobuyuki, Minoru Fujimoto, Fumitaka Terabe, et al.. (2011). Blockade of Interleukin-6 Signaling Suppresses Not Only Th17 but Also Interphotoreceptor Retinoid Binding Protein–Specific Th1 by Promoting Regulatory T Cells in Experimental Autoimmune Uveoretinitis. Investigative Ophthalmology & Visual Science. 52(6). 3264–3264. 67 indexed citations
5.
Terabe, Fumitaka, Minoru Fujimoto, Satoshi Serada, et al.. (2010). Comparative analysis of the effects of anti-IL-6 receptor mAb and anti-TNF mAb treatment on CD4+ T-cell responses in murine colitis. Inflammatory Bowel Diseases. 17(2). 491–502. 14 indexed citations
6.
Ohguro, Nobuyuki, Kei Nakai, Fumitaka Terabe, et al.. (2010). Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses. Experimental Eye Research. 91(2). 162–170. 82 indexed citations
7.
Ripley, Barry, Minoru Fujimoto, Satoshi Serada, et al.. (2010). Green tea polyphenol epigallocatechin gallate inhibits cell signaling by inducing SOCS1 gene expression. International Immunology. 22(5). 359–366. 13 indexed citations
8.
Fujimoto, Minoru, Mayumi Nakano, Fumitaka Terabe, et al.. (2010). The Influence of Excessive IL-6 Production In Vivo on the Development and Function of Foxp3+ Regulatory T Cells. The Journal of Immunology. 186(1). 32–40. 134 indexed citations
9.
Ohguro, Nobuyuki, Fumitaka Terabe, Satoshi Serada, et al.. (2010). PS1-21 Blockade of IL-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses. Cytokine. 52(1-2). 21–21. 5 indexed citations
10.
Serada, Satoshi, Minoru Fujimoto, Atsushi Ogata, et al.. (2009). iTRAQ-based proteomic identification of leucine-rich α-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases. Annals of the Rheumatic Diseases. 69(4). 770–774. 170 indexed citations
11.
Terabe, Fumitaka, Masayasu Kitano, Mari Kawai, et al.. (2009). Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway. Modern Rheumatology. 19(5). 522–529. 19 indexed citations
12.
Terabe, Fumitaka, Masayasu Kitano, Mari Kawai, et al.. (2009). Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway. Modern Rheumatology. 19(5). 522–529. 14 indexed citations
13.
Takahashi, Tsuyoshi, Tetsuji Naka, Minoru Fujimoto, et al.. (2008). Aberrant expression of glycosylation in juvenile gastrointestinal stromal tumors. PROTEOMICS - CLINICAL APPLICATIONS. 2(9). 1246–1254. 5 indexed citations
14.
Fujimoto, Minoru, Fumitaka Terabe, Satoshi Serada, et al.. (2008). Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice. International Immunology. 20(6). 753–762. 72 indexed citations
15.
Serada, Satoshi, Minoru Fujimoto, Masahiko Mihara, et al.. (2008). IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences. 105(26). 9041–9046. 289 indexed citations
16.
Morita, Eijiro, Torao Tanaka, Tetsuya Nakamura, et al.. (2006). CORRELATIONS BETWEEN VIDEO CAPSULE ENDOSCOPIC FINDINGS AND CLINICAL ACTIVITY IN CROHN’S DISEASE. Digestive Endoscopy. 18(4). 263–268. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noriyoshi Ogawa Breakdown of academic impact, for papers by Amer M. Mirza Breakdown of academic impact, for papers by Toshihiro Fukushima Breakdown of academic impact, for papers by Ebrahim Sakhinia Breakdown of academic impact, for papers by Tsan‐Teng Ou Breakdown of academic impact, for papers by Georg Weinlich Breakdown of academic impact, for papers by Dongyi He Breakdown of academic impact, for papers by Weronika Kurowska Breakdown of academic impact, for papers by Kimito Kawahata Breakdown of academic impact, for papers by Ke Liu
Rankless by CCL
2026